Despite Reg Challenges, China Market Access Gradually Improving
This article was originally published in The Gray Sheet
Executive Summary
China’s regulatory environment remains a struggle for device firms seeking to gain marketing or manufacturing footholds in the country, but meaningful government efforts to improve the business climate are making a dent, suggest device executives who are focused on the region.
You may also be interested in...
MITA, AdvaMed Pair Up To Urge Chinese Adoption Of Updated Device Standards
Many countries have already transitioned to the latest edition of the International Engineering Consortium's electromedical equipment standard, but China is one of the last major holdouts, industry reps say.
Boston Sci In China: Investment Chases Big Growth
While Boston Scientific’s core cardiology business units continue to face steep growth challenges in the U.S, China’s massive population remains essentially an untapped market.
Opportunities Ripe For Device Firms In Emerging-Market Heartlands
Device and diagnostics companies can find new growth opportunities by marketing their wares in developing countries' smaller cities and towns, not just big ones, experts said Sept. 30 at a Wells Fargo Securities Emerging Markets Forum in New York